{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:33:56Z","timestamp":1782135236445,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["75N91019D00024"],"award-info":[{"award-number":["75N91019D00024"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.neo.2025.101235","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T22:42:28Z","timestamp":1759876948000},"page":"101235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Metabolic and imaging phenotypes associated with RB1 and TP53 loss in prostate cancer"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7216-5539","authenticated-orcid":false,"given":"Fahim","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Crooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supreet","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8776-5641","authenticated-orcid":false,"given":"Ye","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Capaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonam","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aian Neil","family":"Alilin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Ton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4399-6923","authenticated-orcid":false,"given":"Stephen","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7240-5726","authenticated-orcid":false,"given":"Jurgen","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Olkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali Krishna","family":"Cherukuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1086-8826","authenticated-orcid":false,"given":"Peter L","family":"Choyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7487-6169","authenticated-orcid":false,"given":"Jeffrey R.","family":"Brender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2025.101235_bib0001","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0022-5347(17)70403-X","article-title":"The metabolism of isolated prostatic tissue","volume":"51","author":"Barron","year":"1944","journal-title":"J. Urol."},{"key":"10.1016\/j.neo.2025.101235_bib0002","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000459195","article-title":"Aconitase activity, citrate oxidation, and zinc inhibition in rat ventral prostate","volume":"26","author":"Costello","year":"1981","journal-title":"Enzyme"},{"key":"10.1016\/j.neo.2025.101235_bib0003","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1038\/emboj.2011.158","article-title":"The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis","volume":"30","author":"Massie","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.neo.2025.101235_bib0004","doi-asserted-by":"crossref","first-page":"31997","DOI":"10.18632\/oncotarget.5585","article-title":"Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells","volume":"6","author":"Shafi","year":"2015","journal-title":"Oncotarget."},{"key":"10.1016\/j.neo.2025.101235_bib0005","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nrurol.2016.272","article-title":"A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer","volume":"14","author":"Khan","year":"2017","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.neo.2025.101235_bib0006","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1038\/onc.2013.463","article-title":"Androgens regulate prostate cancer cell growth via an AMPK-PGC-1alpha-mediated metabolic switch","volume":"33","author":"Tennakoon","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2025.101235_bib0007","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neo.2025.101235_bib0008","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/jama.294.4.433","article-title":"Risk of prostate cancer\u2013specific mortality following biochemical recurrence after radical prostatectomy","volume":"294","author":"Freedland","year":"2005","journal-title":"JAMa"},{"key":"10.1016\/j.neo.2025.101235_bib0009","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2490-8-21","article-title":"Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer","volume":"8","author":"Ather","year":"2008","journal-title":"BMC. Urol."},{"key":"10.1016\/j.neo.2025.101235_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejca.2019.08.011","article-title":"Clinical features of neuroendocrine prostate cancer","volume":"121","author":"Conteduca","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.neo.2025.101235_bib0011","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1172\/JCI128212","article-title":"Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer","volume":"129","author":"Labrecque","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neo.2025.101235_bib0012","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.cell.2018.06.039","article-title":"Genomic hallmarks and structural variation in metastatic prostate cancer","volume":"174","author":"Quigley","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.neo.2025.101235_bib0013","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.1073\/pnas.1902651116","article-title":"Genomic correlates of clinical outcome in advanced prostate cancer","volume":"116","author":"Abida","year":"2019","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"key":"10.1016\/j.neo.2025.101235_bib0014","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.neo.2025.101235_bib0015","first-page":"78","article-title":"Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance","volume":"355","author":"Sheng Yu Ku","year":"2017","journal-title":"Science 1979"},{"key":"10.1016\/j.neo.2025.101235_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107669","article-title":"Combined TP53 and RB1 loss promotes prostate cancer resistance to a spectrum of therapeutics and confers vulnerability to replication stress","volume":"31","author":"Nyquist","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.neo.2025.101235_bib0017","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/onc.2016.223","article-title":"Androgen deprivation leads to increased carbohydrate metabolism and hexokinase 2-mediated survival in pten\/Tp53-deficient prostate cancer","volume":"36","author":"Martin","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2025.101235_bib0018","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.semcancer.2021.03.010","article-title":"The complexity of p53-mediated metabolic regulation in tumor suppression","volume":"85","author":"Liu","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.neo.2025.101235_bib0019","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1158\/1078-0432.CCR-18-0409","article-title":"A PDX\/organoid biobank of advanced prostate cancers captures genomic and phenotypic heterogeneity for disease modeling and therapeutic screening","volume":"24","author":"Beshiri","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2025.101235_bib0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nprot.2016.006","article-title":"Organoid culture systems for prostate epithelial and cancer tissue","volume":"11","author":"Drost","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neo.2025.101235_bib0021","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1158\/1535-7163.MCT-19-0936","article-title":"Targeting the PI3K\/AKT pathway overcomes enzalutamide resistance by inhibiting induction of the glucocorticoid receptor","volume":"19","author":"Adelaiye-Ogala","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.neo.2025.101235_bib0022","doi-asserted-by":"crossref","first-page":"8297","DOI":"10.1074\/jbc.RA118.001885","article-title":"Acute loss of iron-sulfur clusters results in metabolic reprogramming and generation of lipid droplets in mammalian cells","volume":"293","author":"Crooks","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neo.2025.101235_bib0023","first-page":"151","article-title":"Sensitivity improvement in proton-detected two-dimensional heteronuclear correlation NMR spectroscopy","volume":"93","author":"Palmer","year":"1991","journal-title":"J. Magn. Reson. 1969"},{"key":"10.1016\/j.neo.2025.101235_bib0024","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46312","article-title":"Imaging of glucose metabolism by 13C-MRI distinguishes pancreatic cancer subtypes in mice","volume":"8","author":"Kishimoto","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.neo.2025.101235_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11040202","article-title":"NMR methods for determining lipid turnover via stable isotope resolved metabolomics","volume":"11","author":"Lin","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.neo.2025.101235_bib0026","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1021\/acs.analchem.0c03070","article-title":"An ion chromatography-ultrahigh-resolution-MS(1)\/data-independent high-resolution MS(2) method for stable isotope-resolved metabolomics reconstruction of Central metabolic networks","volume":"93","author":"Sun","year":"2021","journal-title":"Anal. Chem."},{"key":"10.1016\/j.neo.2025.101235_bib0027","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1158\/0008-5472.CAN-19-0928","article-title":"Molecular imaging of the tumor microenvironment reveals the relationship between tumor oxygenation, glucose uptake, and glycolysis in pancreatic ductal adenocarcinoma","volume":"80","author":"Yamamoto","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101235_bib0028","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.112.112110","article-title":"Acute cytotoxic effects of photoimmunotherapy assessed by 18F-FDG PET","author":"Sano","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neo.2025.101235_bib0029","doi-asserted-by":"crossref","DOI":"10.21105\/joss.02410","article-title":"Viime: visualization and integration of metabolomics experiments","volume":"5","author":"Choudhury","year":"2020","journal-title":"J. Open. Source Softw."},{"key":"10.1016\/j.neo.2025.101235_bib0030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/pros.24497","article-title":"Clinical, pathologic, and molecular features of amphicrine prostate cancer","volume":"83","author":"Graham","year":"2023","journal-title":"Prostate"},{"key":"10.1016\/j.neo.2025.101235_bib0031","doi-asserted-by":"crossref","first-page":"T51","DOI":"10.1530\/ERC-21-0002","article-title":"The heterogeneity of prostate cancers lacking AR activity will require diverse treatment approaches","volume":"28","author":"Labrecque","year":"2021","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.neo.2025.101235_bib0032","unstructured":"(!!! Invalid citation !!!)."},{"key":"10.1016\/j.neo.2025.101235_bib0033","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends. Biochem. Sci."},{"key":"10.1016\/j.neo.2025.101235_bib0034","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/ng.3967","article-title":"Patient-derived xenografts undergo mouse-specific tumor evolution","volume":"49","author":"Ben-David","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neo.2025.101235_bib0035","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid cultures derived from patients with advanced prostate cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.neo.2025.101235_bib0036","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/path.5698","article-title":"Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens","volume":"254","author":"Servant","year":"2021","journal-title":"J. Pathol."},{"key":"10.1016\/j.neo.2025.101235_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25021093","article-title":"Organoids: an emerging precision medicine model for prostate cancer research","volume":"25","author":"Waseem","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2025.101235_bib0038","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1038\/s41467-022-30257-z","article-title":"MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets","volume":"13","author":"Qiu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2025.101235_bib0039","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1158\/1078-0432.CCR-22-0851","article-title":"Assessment of androgen receptor splice variant-7 as a biomarker of clinical response in castration-sensitive prostate cancer","volume":"28","author":"Sowalsky","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2025.101235_bib0040","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","article-title":"Cell-programmed nutrient partitioning in the tumour microenvironment","volume":"593","author":"Reinfeld","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.neo.2025.101235_bib0041","first-page":"2227","article-title":"Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells","volume":"62","author":"Zhuang","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101235_bib0042","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.1158\/0008-5472.CAN-07-5997","article-title":"Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer","volume":"68","author":"Locke","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101235_bib0043","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/pros.21072","article-title":"Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model","volume":"70","author":"Leon","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.neo.2025.101235_bib0044","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/pros.23313","article-title":"LuCaP prostate cancer patient-derived xenografts reflect the molecular heterogeneity of advanced disease an\u2013d serve as models for evaluating cancer therapeutics","volume":"77","author":"Nguyen","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.neo.2025.101235_bib0045","first-page":"49-62 e48","article-title":"Four key steps control glycolytic flux in mammalian cells","volume":"7","author":"Tanner","year":"2018","journal-title":"Cell Syst."},{"key":"10.1016\/j.neo.2025.101235_bib0046","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S1470-2045(22)00605-2","article-title":"PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [(177)Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial","volume":"23","author":"Buteau","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.neo.2025.101235_bib0047","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/RLU.0000000000004196","article-title":"Utility of PET to appropriately select patients for PSMA-targeted theranostics","volume":"47","author":"Eshghi","year":"2022","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.neo.2025.101235_bib0048","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2967\/jnumed.122.264741","article-title":"Is (18)F-FDG PET needed to assess (177)Lu-PSMA therapy eligibility? A vision-like, single-center analysis","volume":"64","author":"Seifert","year":"2023","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neo.2025.101235_bib0049","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2967\/jnumed.112.114116","article-title":"Baseline 18F-FDG PET\/CT parameters as imaging biomarkers of overall survival in castrate-resistant metastatic prostate cancer","volume":"54","author":"Jadvar","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neo.2025.101235_bib0050","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.eururo.2019.03.020","article-title":"Genomic drivers of poor prognosis and enzalutamide resistance in metastatic castration-resistant prostate cancer","volume":"76","author":"Chen","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.neo.2025.101235_bib0051","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11020257","article-title":"The role of lactate metabolism in prostate cancer progression and metastases revealed by dual-agent hyperpolarized (13)C MRSI","volume":"11","author":"Bok","year":"2019","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.neo.2025.101235_bib0052","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/path.4547","article-title":"A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy","volume":"236","author":"Pertega-Gomes","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.neo.2025.101235_bib0053","first-page":"1165","article-title":"Presence of glycogen and growth-related variations in 58 cultured human tumor cell lines of various tissue origins","volume":"41","author":"Rousset","year":"1981","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101235_bib0054","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fonc.2012.00018","article-title":"Glycogen synthesis is induced in hypoxia by the hypoxia-inducible factor and promotes cancer cell survival","volume":"2","author":"Pelletier","year":"2012","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neo.2025.101235_bib0055","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.trecan.2017.09.007","article-title":"The glycogen shunt maintains glycolytic homeostasis and the Warburg effect in cancer","volume":"3","author":"Shulman","year":"2017","journal-title":"Trends. Cancer"},{"key":"10.1016\/j.neo.2025.101235_bib0056","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","article-title":"Lactate modulation of immune responses in inflammatory versus tumour microenvironments","volume":"21","author":"Certo","year":"2021","journal-title":"Nat. Rev. Immunol."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625001150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625001150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T22:26:58Z","timestamp":1762381618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558625001150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":56,"alternative-id":["S1476558625001150"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2025.101235","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic and imaging phenotypes associated with RB1 and TP53 loss in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2025.101235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101235"}}